181 related articles for article (PubMed ID: 15664819)
1. Novel spiroanellated 1,2,4-trioxanes with high in vitro antimalarial activities.
Griesbeck AG; El-Idreesy TT; Höinck LO; Lex J; Brun R
Bioorg Med Chem Lett; 2005 Feb; 15(3):595-7. PubMed ID: 15664819
[TBL] [Abstract][Full Text] [Related]
2. Enantiomeric 1,2,4-trioxanes display equivalent in vitro antimalarial activity versus Plasmodium falciparum malaria parasites: implications for the molecular mechanism of action of the artemisinins.
O'Neill PM; Rawe SL; Borstnik K; Miller A; Ward SA; Bray PG; Davies J; Oh CH; Posner GH
Chembiochem; 2005 Nov; 6(11):2048-54. PubMed ID: 16222725
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of antimalarial 1,2,4-trioxanes via photooxygenation of a chiral allylic alcohol.
Griesbeck AG; El-Idreesy TT; Fiege M; Brun R
Org Lett; 2002 Nov; 4(24):4193-5. PubMed ID: 12443056
[TBL] [Abstract][Full Text] [Related]
4. Novel bis- and tris-1,2,4-trioxanes: synthesis and antimalarial activity against multidrug-resistant Plasmodium yoelii in Swiss mice.
Singh C; Verma VP; Naikade NK; Singh AS; Hassam M; Puri SK
J Med Chem; 2008 Dec; 51(23):7581-92. PubMed ID: 19006381
[TBL] [Abstract][Full Text] [Related]
5. Effect of functional group polarity on the antimalarial activity of spiro and dispiro-1,2,4-trioxolanes.
Dong Y; Tang Y; Chollet J; Matile H; Wittlin S; Charman SA; Charman WN; Tomas JS; Scheurer C; Snyder C; Scorneaux B; Bajpai S; Alexander SA; Wang X; Padmanilayam M; Cheruku SR; Brun R; Vennerstrom JL
Bioorg Med Chem; 2006 Sep; 14(18):6368-82. PubMed ID: 16759871
[TBL] [Abstract][Full Text] [Related]
6. Orally active 1,2,4-trioxanes: synthesis and antimalarial assessment of a new series of 9-functionalized 3-(1-arylvinyl)-1,2,5-trioxaspiro[5.5]undecanes against multi-drug-resistant plasmodium yoelii nigeriensis in mice.
Singh C; Malik H; Puri SK
J Med Chem; 2006 May; 49(9):2794-803. PubMed ID: 16640340
[TBL] [Abstract][Full Text] [Related]
7. New adamantane-based spiro 1,2,4-trioxanes orally effective against rodent and simian malaria.
Singh C; Kanchan R; Sharma U; Puri SK
J Med Chem; 2007 Feb; 50(3):521-7. PubMed ID: 17266204
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Biological Evaluation of Novel 1,2,4-Trioxanes as Potential Antimalarial Agents.
Gupta AK; Varshney K; Kumar V; Srivastava K; Pant AB; Puri SK; Saxena AK
Arch Pharm (Weinheim); 2017 Apr; 350(3-4):. PubMed ID: 28207169
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, in vitro and in vivo antimalarial assessment of sulfide, sulfone and vinyl amide-substituted 1,2,4-trioxanes prepared via thiol-olefin co-oxygenation (TOCO) of allylic alcohols.
Amewu R; Gibbons P; Mukhtar A; Stachulski AV; Ward SA; Hall C; Rimmer K; Davies J; Vivas L; Bacsa J; Mercer AE; Nixon G; Stocks PA; O'Neill PM
Org Biomol Chem; 2010 May; 8(9):2068-77. PubMed ID: 20401383
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimalarial assessment of a new series of orally active amino-functionalized spiro 1,2,4-trioxanes.
Singh C; Hassam M; Naikade NK; Verma VP; Singh AS; Puri SK
J Med Chem; 2010 Nov; 53(21):7587-98. PubMed ID: 20936847
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antimalarial activity of 11 dispiro-1,2,4,5-tetraoxane analogues of WR 148999. 7,8,15,16-Tetraoxadispiro[5.2.5.2]hexadecanes substituted at the 1 and 10 positions with unsaturated and polar functional groups.
Dong Y; Matile H; Chollet J; Kaminsky R; Wood JK; Vennerstrom JL
J Med Chem; 1999 Apr; 42(8):1477-80. PubMed ID: 10212135
[TBL] [Abstract][Full Text] [Related]
12. The structure-activity relationship of the antimalarial ozonide arterolane (OZ277).
Dong Y; Wittlin S; Sriraghavan K; Chollet J; Charman SA; Charman WN; Scheurer C; Urwyler H; Santo Tomas J; Snyder C; Creek DJ; Morizzi J; Koltun M; Matile H; Wang X; Padmanilayam M; Tang Y; Dorn A; Brun R; Vennerstrom JL
J Med Chem; 2010 Jan; 53(1):481-91. PubMed ID: 19924861
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and in vitro cancer cell growth inhibition evaluation and antimalarial testing of trioxanes installed in cyclic 2-enoate substructures.
Hossain MI; Świtalska M; Peng W; Takashima M; Wang N; Kaiser M; Wietrzyk J; Dan S; Yamori T; Inokuchi T
Eur J Med Chem; 2013 Nov; 69():294-309. PubMed ID: 24056020
[TBL] [Abstract][Full Text] [Related]
14. Mechanism-based design, synthesis, and in vitro antimalarial testing of new 4-methylated trioxanes structurally related to artemisinin: the importance of a carbon-centered radical for antimalarial activity.
Posner GH; Oh CH; Wang D; Gerena L; Milhous WK; Meshnick SR; Asawamahasadka W
J Med Chem; 1994 Apr; 37(9):1256-8. PubMed ID: 8176702
[No Abstract] [Full Text] [Related]
15. Application of thiol-olefin co-oxygenation methodology to a new synthesis of the 1,2,4-trioxane pharmacophore.
O'Neill PM; Mukhtar A; Ward SA; Bickley JF; Davies J; Bachi MD; Stocks PA
Org Lett; 2004 Sep; 6(18):3035-8. PubMed ID: 15330581
[TBL] [Abstract][Full Text] [Related]
16. Pharmacophore modeling of substituted 1,2,4-Trioxanes for quantitative prediction of their antimalarial activity.
Gupta AK; Chakroborty S; Srivastava K; Puri SK; Saxena AK
J Chem Inf Model; 2010 Aug; 50(8):1510-20. PubMed ID: 20726605
[TBL] [Abstract][Full Text] [Related]
17. Two-step synthesis of achiral dispiro-1,2,4,5-tetraoxanes with outstanding antimalarial activity, low toxicity, and high-stability profiles.
Ellis GL; Amewu R; Sabbani S; Stocks PA; Shone A; Stanford D; Gibbons P; Davies J; Vivas L; Charnaud S; Bongard E; Hall C; Rimmer K; Lozanom S; Jesús M; Gargallo D; Ward SA; O'Neill PM
J Med Chem; 2008 Apr; 51(7):2170-7. PubMed ID: 18341274
[TBL] [Abstract][Full Text] [Related]
18. Spiro and dispiro-1,2,4-trioxolanes as antimalarial peroxides: charting a workable structure-activity relationship using simple prototypes.
Dong Y; Chollet J; Matile H; Charman SA; Chiu FC; Charman WN; Scorneaux B; Urwyler H; Santo Tomas J; Scheurer C; Snyder C; Dorn A; Wang X; Karle JM; Tang Y; Wittlin S; Brun R; Vennerstrom JL
J Med Chem; 2005 Jul; 48(15):4953-61. PubMed ID: 16033274
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antimalarial activity of novel synthetic aculeatin derivatives.
Peuchmaur M; Saïdani N; Botté C; Maréchal E; Vial H; Wong YS
J Med Chem; 2008 Aug; 51(16):4870-3. PubMed ID: 18680278
[TBL] [Abstract][Full Text] [Related]
20. Orally active antimalarials: synthesis and bioevaluation of a new series of steroid-based 1,2,4-trioxanes against multi-drug resistant malaria in mice.
Singh C; Sharma U; Saxena G; Puri SK
Bioorg Med Chem Lett; 2007 Aug; 17(15):4097-101. PubMed ID: 17548195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
